INTRODUCTION: A fraction of fibrinogen molecules contain an alternatively spliced variant chain called gamma'. Plasma levels of this variant have been associated with both myocardial infarction and venous thrombosis. Because clot structure has been associated with cardiovascular risk, we examined the effect of gamma' chain on clot structure. MATERIALS AND METHODS: We expressed three fibrinogen variants in Chinese hamster ovary (CHO) cells: gamma/gamma homodimer, gamma/gamma' heterodimer, and gamma'/gamma' homodimer. We observed thrombin-catalyzed fibrinopeptide release by HPLC, fibrin polymerization by turbidity, and clot structure by scanning electron microscopy. We characterized post-translational modifications by mass spectrometry. RESULTS: Fibrinopeptide A was released at the same rate for all three fibrinogens, while fibrinopeptide B was released faster from the gamma'/gamma' homodimer. The rise in turbidity was slower and final absorbance was lower during polymerization of gamma'-containing fibrinogens than for gamma/gamma fibrinogen. Micrographs showed that gamma'/gamma' fibrin clots are composed of very thin fibers, while the diameter of gamma/gamma' fibers is similar to gamma/gamma fibers. Further, the fiber networks formed from gamma'-containing samples were non-uniform. Mass spectrometry showed heterogeneous addition of N-glycans and tyrosine sulfation in the gamma' chain. CONCLUSIONS: The presence of gamma' chains slows lateral aggregation and alters fibrin structure. We suggest these changes are likely due to charge-charge repulsion, such that polymerization of the gamma'/gamma' homodimer is more impaired than the heterodimer since these repulsions are partially offset by incorporation of gamma chains in the gamma/gamma' heterodimer.
INTRODUCTION: A fraction of fibrinogen molecules contain an alternatively spliced variant chain called gamma'. Plasma levels of this variant have been associated with both myocardial infarction and venous thrombosis. Because clot structure has been associated with cardiovascular risk, we examined the effect of gamma' chain on clot structure. MATERIALS AND METHODS: We expressed three fibrinogen variants in Chinese hamster ovary (CHO) cells: gamma/gamma homodimer, gamma/gamma' heterodimer, and gamma'/gamma' homodimer. We observed thrombin-catalyzed fibrinopeptide release by HPLC, fibrin polymerization by turbidity, and clot structure by scanning electron microscopy. We characterized post-translational modifications by mass spectrometry. RESULTS: Fibrinopeptide A was released at the same rate for all three fibrinogens, while fibrinopeptide B was released faster from the gamma'/gamma' homodimer. The rise in turbidity was slower and final absorbance was lower during polymerization of gamma'-containing fibrinogens than for gamma/gamma fibrinogen. Micrographs showed that gamma'/gamma' fibrin clots are composed of very thin fibers, while the diameter of gamma/gamma' fibers is similar to gamma/gamma fibers. Further, the fiber networks formed from gamma'-containing samples were non-uniform. Mass spectrometry showed heterogeneous addition of N-glycans and tyrosine sulfation in the gamma' chain. CONCLUSIONS: The presence of gamma' chains slows lateral aggregation and alters fibrin structure. We suggest these changes are likely due to charge-charge repulsion, such that polymerization of the gamma'/gamma' homodimer is more impaired than the heterodimer since these repulsions are partially offset by incorporation of gamma chains in the gamma/gamma' heterodimer.
Authors: J P Collet; D Park; C Lesty; J Soria; C Soria; G Montalescot; J W Weisel Journal: Arterioscler Thromb Vasc Biol Date: 2000-05 Impact factor: 8.311
Authors: Kevin R Siebenlist; Michael W Mosesson; Irene Hernandez; Leslie A Bush; Enrico Di Cera; John R Shainoff; James P Di Orio; Laurie Stojanovic Journal: Blood Date: 2005-07-07 Impact factor: 22.113
Authors: M N Mannila; R S Lovely; S C Kazmierczak; P Eriksson; A Samnegård; D H Farrell; A Hamsten; A Silveira Journal: J Thromb Haemost Date: 2007-01-22 Impact factor: 5.824
Authors: Elim Y L Cheung; Shirley Uitte de Willige; Hans L Vos; Frank W G Leebeek; Diederik W J Dippel; Rogier M Bertina; Moniek P M de Maat Journal: Stroke Date: 2008-01-31 Impact factor: 7.914
Authors: Rehana S Lovely; Steven C Kazmierczak; Joseph M Massaro; Ralph B D'Agostino; Christopher J O'Donnell; David H Farrell Journal: Clin Chem Date: 2010-03-26 Impact factor: 8.327
Authors: Rehana S Lovely; Qiong Yang; Joseph M Massaro; Jing Wang; Ralph B D'Agostino; Christopher J O'Donnell; Jackilen Shannon; David H Farrell Journal: Arterioscler Thromb Vasc Biol Date: 2011-07-14 Impact factor: 8.311
Authors: Elim Y L Cheung; Ester M Weijers; Bastiaan Tuk; Reinilde Scheffer; Frank W Leebeek; Johan W van Neck; Pieter Koolwijk; Moniek P M de Maat Journal: Tissue Eng Part A Date: 2014-08-05 Impact factor: 3.845
Authors: Paul Y Kim; Trang T Vu; Beverly A Leslie; Alan R Stafford; James C Fredenburgh; Jeffrey I Weitz Journal: J Biol Chem Date: 2014-08-15 Impact factor: 5.157
Authors: James R Byrnes; Clare Wilson; Anthony M Boutelle; Chase B Brandner; Matthew J Flick; Helen Philippou; Alisa S Wolberg Journal: Blood Date: 2016-08-25 Impact factor: 22.113